PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.40
Bid: 51.70
Ask: 52.00
Change: -1.30 (-2.47%)
Spread: 0.30 (0.58%)
Open: 55.00
High: 55.00
Low: 51.40
Prev. Close: 52.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group portfolio company First Light achieves projectile fusion

Tue, 05th Apr 2022 09:00

(Alliance News) - IP Group PLC said on Tuesday that its stake in its portfolio company First Light Fusion Ltd is set to double after the company achieved fusion.

The London-based intellectual property commercialisation company noted First Light's achievement of fusion with a projectile approach; the first of its kind, which has been independently validated by the UK Atomic Energy Authority.

"Instead of using complex and expensive lasers or magnets to generate or maintain the conditions for fusion, First Light's approach compresses the fuel inside a target using a projectile travelling at tremendous speed," First Light explained.

First Light, a University of Oxford spin-out company, said it believes this approach is faster, simpler and cheaper than other routes to commercial fusion power. It achieved fusion with a spend of less than GBP45 million.

IP Group said its 27% holding in First Light was valued at GBP57.3 million at December 31, and it now expects the value to double by around GBP57 million, or around 5 pence per share.

It also noted recent comparatives and third party valuation work which suggest First Light's valuation could double or quadruple in the next funding round.

Shares in IP Group were up 4.4% to 93.71 pence each in London on Tuesday morning, the top FTSE 250 gainer.

"Following the success of Oxford Nanopore, Ceres Power and others, this is another example of IP Group having helped establish a business with the potential to have enormous impact and supporting it over many years to a significant inflexion point. We continue to have strong conviction in the company and the potential its technology offers," said IP Chief Executive Officer Greg Smith.

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
15 Nov 2021 14:15

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

Read more
11 Nov 2021 14:57

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

IN BRIEF: Ceres Power strikes deal with IP Group investee RFC

Read more
11 Nov 2021 09:18

IP Group portfolio company inks joint development agreement with Ceres Power

(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, had signed a joint development agreement with fuel cell technology firm Ceres Power.

Read more
29 Oct 2021 14:36

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

IN BRIEF: IP Group investee Hinge Health valued at over USD6 billion

Read more
25 Oct 2021 16:10

IN BRIEF: IP Group books GBP27.5 million fair value gain

IN BRIEF: IP Group books GBP27.5 million fair value gain

Read more
25 Oct 2021 08:42

IP Group records £27.5m value gain after recent funding round

(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.

Read more
19 Oct 2021 10:50

Oxford BioMedica licences technology for cystic fibrosis treatment

Oxford BioMedica licences technology for cystic fibrosis treatment

Read more
19 Oct 2021 09:18

Boehringer Ingelheim licenses Oxford Biomedica's lentiviral vector technology

(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.

Read more
12 Oct 2021 14:40

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

IN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares

Read more
6 Oct 2021 12:11

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

LONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear

Read more
6 Oct 2021 09:26

IP Group CEO, CIO step down after Oxford Nanopore IPO

(Sharecast News) - IP Group said on Wednesday that chief executive Alan Aubrey and chief investment officer Mike Townend are retiring and stepping down from the board with immediate effect following the successful flotation of its largest holding, Oxford Nanopore Technologies.

Read more
6 Oct 2021 09:18

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

TOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group

Read more
30 Sep 2021 12:11

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

LONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut

Read more
30 Sep 2021 10:47

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

UPDATE: Oxford Nanopore nears GBP5 billion value in London debut

Read more
30 Sep 2021 10:42

Shares soar as Oxford Nanopore makes its London debut

(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.